Back

Ranolazine protects from trastuzumab cardiomyopathy

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Basic Science: Co-morbidities Cancer/Cardiotoxicity HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Nicola Maurea

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)

4 More presentations in this session

Presentation thumbnail
Enalapril, eplerenone or their combination: finding the best paradigm to protect against Doxorubicin-Induced Cardiotoxicity
Professor R. Hullin (Lausanne, CH)
Abstract
Presentation thumbnail
Sildenafil treatment in a rat model of cancer cachexia
Doctor S. Nucera (Catanzaro, IT)
Abstract
Presentation thumbnail
Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity in vitro and in vivo
Professor W. Kim (Seoul, KR)
Presentation thumbnail
TLR4 and TLR2 detection method from peripheral human blood for early detection of doxorubicin induced cardiotoxicity
Assistant Professor M. Trofenciuc (Arad, RO)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Basic Science: Co-morbidities

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources